CONDITION

Blood Transfusion Reaction

A blood transfusion reaction occurs when the immune system responds to donated blood in a way that causes unwanted effects. Most animals receiving a transfusion tolerate it well, and where a reaction does occur, a mild and self-limiting rise in temperature is the most commonly reported pattern; reactions can nonetheless range from mild and transient to severe and life-threatening. These reactions may begin during the transfusion itself or appear hours to days afterwards. Owners may notice sudden restlessness, changes in breathing, vomiting, or collapse during or shortly after a transfusion, though many reactions produce subtler signs such as fever, dark urine, or a temporary worsening of weakness. The pattern and timing of signs can offer clues about the type of reaction involved. This page explores the signals that may suggest a transfusion reaction, the immune and physiological mechanisms that underlie different reaction types, the investigations used to identify and characterise a reaction, and the approaches available for management and prevention in animals who may need future transfusions.

Why this matters now

Blood transfusion reactions can occur in any animal receiving donated blood, regardless of age or breed. The risk varies with transfusion history: animals receiving their first transfusion tend to have a lower risk of immediate severe reactions, whilst those who have had previous transfusions or pregnancies may have developed antibodies that increase the likelihood of a response. Cats carry naturally occurring antibodies against certain blood types, which means even first-time feline recipients can experience acute reactions if blood typing and crossmatching are not performed.

The timing of a transfusion reaction varies with its type. Acute reactions typically begin within minutes to hours of starting the transfusion, often whilst the animal is still receiving blood or under close observation. Delayed reactions may not become apparent until several days afterwards, when the initial monitoring period has passed and subtler signs such as persistent weakness, jaundice, or dark urine emerge. Some reactions resolve spontaneously once the transfusion is stopped, whilst others progress and require active intervention to prevent organ damage or collapse.

Signals & patterns

Early signals

Sudden restlessness or agitation

An animal may become unexpectedly unsettled during the transfusion, shifting position frequently, panting, or appearing uncomfortable. This can reflect early circulatory or immune activation before more obvious physical signs appear.

Facial swelling or hives

Raised welts or puffiness around the face, eyelids, or muzzle can develop quickly during or shortly after a transfusion. These changes indicate an allergic-type response to proteins in the donated blood.

Vomiting or drooling

Some animals begin to salivate heavily or vomit within the first minutes to hours of receiving blood. This may accompany other signs of immune activation or circulatory stress.

Increased breathing rate

Faster or more laboured breathing can signal a mismatch between the body's oxygen needs and what the transfused blood is delivering, or reflect early fluid overload in the lungs. This change may be subtle at first.

Fever

A rise in body temperature during or shortly after transfusion often reflects the immune system responding to white blood cells, platelets, or proteins in the donor blood, and is the most commonly reported pattern of transfusion reaction. The animal may feel warm to the touch or appear lethargic, and in many cases the fever settles on its own once the transfusion is paused, without further treatment.

Later signals

Dark or red-tinged urine

Urine that appears brown, red, or port-wine coloured indicates that red blood cells are being destroyed and their contents released into the bloodstream and filtered by the kidneys. This sign may not be noticed until the animal urinates hours after the transfusion.

Yellowing of gums or skin

Jaundice can develop over days as the liver processes the breakdown products of destroyed red blood cells. The yellowing is often most visible in the whites of the eyes, gums, or areas of pale skin.

Persistent or worsening weakness

Rather than improving after transfusion, the animal may remain weak or become more lethargic. This can indicate that the transfused cells are being destroyed rather than circulating effectively, or that organ function is declining.

Reduced urine output

A noticeable drop in the frequency or volume of urination over the days following transfusion may reflect kidney injury from circulating breakdown products or reduced blood flow. This sign requires careful observation of litter tray habits or outdoor toileting.

Click to read about the biological mechanisms

How this is usually investigated

The investigation of a suspected transfusion reaction typically begins with close observation during and after the transfusion, noting the timing and pattern of any new signs. A comparison of pre-transfusion and post-transfusion blood samples can reveal changes in red blood cell count, haemoglobin concentration, and markers of haemolysis or immune activation. Further tests are selected based on the clinical picture, aiming to distinguish between different reaction types and assess the degree of organ involvement.

Complete blood count

Purpose: A post-transfusion blood count is compared with the pre-transfusion baseline to assess whether the expected rise in red blood cell count has occurred, or whether haemolysis has prevented the expected improvement. The presence of agglutination, spherocytes, or ghost cells on the blood smear can suggest immune-mediated destruction of donor cells.
Considerations: The count alone cannot confirm the cause of a reaction, and changes may not become apparent until several hours after the transfusion begins. A rising haematocrit may mask ongoing low-grade haemolysis in some cases.

Urinalysis with sediment

Purpose: Examination of the urine can reveal haemoglobinuria—free haemoglobin spilling into the urine—which produces a dark red or brown colour and suggests intravascular haemolysis. The sediment is assessed for pigment casts, which indicate tubular injury from excessive haemoglobin or bilirubin.
Considerations: Haemoglobinuria may be transient and can be missed if urine is not collected soon after the reaction begins. Discolouration can also result from myoglobin in cases of muscle injury, requiring correlation with other findings.

Chemistry panel

Purpose: Biochemistry reveals rises in bilirubin—indicating breakdown of red blood cells—and allows assessment of kidney function through urea and creatinine. Electrolyte disturbances and changes in liver enzymes may also be detected if the reaction has triggered broader metabolic consequences.
Considerations: Bilirubin may not rise noticeably until several hours or days after haemolysis begins, particularly in delayed reactions. Pre-existing liver or kidney disease can complicate interpretation of post-transfusion values.

Blood typing and crossmatching

Purpose: Retrospective blood typing and crossmatching of donor and recipient samples can identify incompatibilities that were missed or not checked before the transfusion. A positive major crossmatch—where recipient serum reacts with donor cells—suggests the presence of antibodies against donor red blood cell antigens.
Considerations: Crossmatching is most informative when performed before a transfusion; post-reaction testing may be complicated by circulating donor cells and newly formed antibodies. In cats, naturally occurring alloantibodies mean that even first-time recipients require typing and matching.

Direct antiglobulin test (Coombs test)

Purpose: This test detects antibodies or complement fragments bound to the surface of red blood cells, which can help confirm immune-mediated destruction. A positive result supports the diagnosis of an immune-mediated haemolytic reaction, though it does not distinguish between transfusion-related and spontaneous immune-mediated haemolytic anaemia.
Considerations: The test may be negative in acute reactions if most antibody-coated cells have already been destroyed, and it can be positive in animals with concurrent autoimmune disease unrelated to the transfusion. Timing of sample collection relative to the reaction influences sensitivity.

Respiratory rate, effort and lung auscultation

Purpose: Regular checks of breathing rate and effort, together with listening to the lungs, can identify fluid accumulating in the lungs when blood or fluid has been given faster or in a greater volume than the heart and circulation can accommodate—a pattern called transfusion-associated circulatory overload. This produces laboured breathing and sometimes coughing, distinct from the fever more typical of a mild immune reaction to donor white cells or plasma proteins.
Considerations: Laboured breathing can also reflect an allergic-type reaction, the underlying anaemia itself, or pre-existing heart or lung disease, so the pattern and timing of the change, together with the rate and volume of blood or fluid already given, help distinguish between these possibilities.

Options & trade-offs

Management of a transfusion reaction is tailored to the type and severity of the response, the animal's underlying condition, and the degree of organ involvement. Many mild reactions are managed by stopping the transfusion and providing supportive care, whilst more severe reactions may require specific interventions to limit immune activation, support blood pressure, and protect kidney function. The choice of approach depends on balancing the need to manage the reaction against the animal's ongoing requirement for blood support.

Stopping the transfusion and supportive care

Discontinuing or slowing the transfusion limits further immune activation and, where breathing difficulty reflects the volume of fluid given rather than an immune reaction, reduces the load on the heart and lungs. Intravenous fluids may be given to support blood pressure, maintain kidney perfusion, and dilute circulating haemoglobin in reactions driven by immune-mediated cell destruction, though additional fluid is reduced or withheld where breathing difficulty instead reflects circulatory overload from the transfusion itself—a distinct pattern, sometimes called transfusion-associated circulatory overload, that tends to improve with a slower rate or a diuretic rather than more fluid. Oxygen supplementation can be provided if breathing is compromised or if anaemia worsens during the reaction.

Trade-offs: Stopping the transfusion may leave the animal without sufficient red blood cells if the reaction occurs early and little blood has been delivered. Some animals continue to haemolyse transfused cells even after the infusion is stopped, particularly in delayed reactions where antibodies persist in the circulation. Because a raised temperature, laboured breathing, or general discomfort can arise from several different reaction types, correctly identifying which is occurring shapes whether fluids are increased, reduced, or withheld, and mild febrile reactions in particular often need no more than pausing the transfusion and monitoring.

Anti-inflammatory and immunosuppressive drugs

Corticosteroids such as dexamethasone or prednisolone can be administered to reduce immune activation and suppress further antibody-mediated destruction of donor cells. Antihistamines may be given in allergic-type reactions to counteract histamine release and reduce swelling, hives, and vascular leakage. These medications are often given at the first sign of a reaction, particularly if signs progress during the transfusion.

Trade-offs: Corticosteroids do not reverse haemolysis that has already occurred and may not prevent severe reactions if large volumes of incompatible blood have been transfused. Antihistamines are less effective once widespread mediator release has occurred, and their sedative effects can complicate assessment of neurological status in unwell animals.

Washed or crossmatch-compatible blood products

If the animal requires ongoing transfusion support despite the reaction, washed red blood cells—where donor plasma has been removed—can reduce the risk of reactions caused by plasma proteins or antigens. Crossmatch-compatible units, ideally from a typed donor, are selected to minimise the risk of further immune-mediated destruction. In some cases, fresh frozen plasma or synthetic colloids are used instead of whole blood to provide volume support without introducing additional red cell antigens.

Trade-offs: Washed cells and typed blood may not be readily available in all settings, and the preparation process takes time. Even crossmatch-negative units can occasionally provoke reactions if minor antigens are involved, and animals with multiple prior transfusions may develop antibodies that make finding compatible blood increasingly difficult.

Monitoring and organ support

Serial assessment of kidney function, urine output, and electrolyte balance helps detect early tubular injury from haemoglobin or bilirubin deposition. Fluid therapy rates and composition are adjusted to maintain renal perfusion and encourage diuresis, which can help clear pigment from the tubules. In severe cases, blood pressure monitoring and vasopressor support may be needed if vascular leakage or complement activation causes hypotension.

Trade-offs: Intensive monitoring requires hospitalisation and repeated blood sampling, which adds to the cost and stress of treatment. Some animals develop acute kidney injury despite aggressive fluid therapy, particularly if haemolysis is severe or if pre-existing kidney disease limits reserve capacity.

Common misconceptions

Misconception:

"A transfusion reaction means the vet made a mistake with blood typing or matching."

Reality:

Reactions can occur even when typing and crossmatching are performed correctly, particularly in animals with prior transfusion or pregnancy exposure who have developed antibodies against less common blood group antigens not detected by standard tests. Some reactions are non-haemolytic and result from immune responses to white blood cells, platelets, or plasma proteins rather than red cell incompatibility.

Misconception:

"If a dog has had a transfusion before without problems, future transfusions will also be safe."

Reality:

Prior transfusions can sensitise the immune system, leading to the formation of antibodies that increase the risk of a reaction during subsequent transfusions. Cats and dogs both develop alloantibodies after exposure to foreign blood, and the risk of a reaction tends to rise with each additional transfusion, particularly if weeks or months have passed since the last one.

Misconception:

"Dark urine after a transfusion always means the kidneys are failing."

Reality:

Dark urine often reflects haemoglobinuria—the excretion of free haemoglobin released from destroyed red blood cells—rather than primary kidney failure. Whilst high levels of haemoglobin can injure the kidney tubules and lead to acute tubular damage, many animals clear the pigment without lasting impairment if the reaction is recognised early and fluid support is provided.

Misconception:

"Every reaction during a transfusion is a dangerous, life-threatening event."

Reality:

The most commonly reported transfusion reaction in dogs and cats is a mild, self-limiting rise in body temperature—a febrile non-haemolytic reaction—caused by the recipient's immune response to white blood cells, platelets, or proteins in the donor blood rather than destruction of red blood cells. This type of reaction often settles without specific treatment once the transfusion is paused, though any new sign during a transfusion is still noted and assessed, since a raised temperature can also mark the start of a more significant reaction.

Related conditions

Babesiosis

Babesiosis destroys red blood cells through parasitic invasion, which can lead to severe anaemia requiring blood transfusion as supportive care. Animals with babesiosis who receive transfusions may face additional immune complexity, as their immune system is already responding to the parasite-infected cells.

Anticoagulant Rodenticide Toxicity

Anticoagulant rodenticide toxicity can cause life-threatening bleeding that may require blood transfusion to replace lost red blood cells and clotting factors. The need for transfusion in this context arises from haemorrhage rather than immune destruction, though the transfusion itself still carries the same range of potential reactions.

Allium Toxicity (Onion and Garlic)

Allium toxicity damages red blood cells in a way that causes them to rupture, producing anaemia that can sometimes become severe enough to require blood transfusion. The decision to transfuse depends on how rapidly the red cell count falls and how well the animal is compensating.

Atopic Dermatitis in Dogs

Atopic dermatitis involves an overactive immune response to environmental triggers, and while it affects the skin rather than the blood, it reflects a broader pattern of immune hypersensitivity that may, in some cases, influence how an individual's immune system responds to foreign proteins during a transfusion.

Acute Moist Dermatitis (Hot Spots)

Acute moist dermatitis is an inflammatory skin condition that typically arises from localised irritation or allergy, and though it does not directly relate to transfusion, both conditions involve immune-mediated tissue responses that can appear suddenly and range from mild to severe depending on the individual's reactivity.

If an animal has experienced a transfusion reaction, future transfusion needs can become more complex, and understanding the type of reaction and the antibodies involved may influence planning for surgery, trauma, or conditions that cause ongoing anaemia. Animals with chronic diseases that may require repeated transfusions—such as immune-mediated haemolytic anaemia or bleeding disorders—benefit from discussions about the availability of typed donors, the role of crossmatching, and the practicalities of managing transfusion-dependent cases over time. The immune and inflammatory mechanisms that underlie transfusion reactions overlap with those seen in autoimmune and hypersensitivity conditions, and exploring those broader immune patterns can provide useful context for owners navigating complex or recurrent illness.

Last reviewed: 13 September 2026 · Dr Alastair Greenway MRCVS